Intercellular mitochondrial transfer in melanoma progression and therapeutic resistance: mechanisms and targeting potential - Top-Institutions - MDSpire

Intercellular mitochondrial transfer in melanoma progression and therapeutic resistance: mechanisms and targeting potential

  • By

  • Qingqing Yan

  • Tao Sun

  • Kang Chen

  • Hao Hu

  • May 21, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology
    • Melanoma

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology
    • Melanoma

  • #3

    Institut Gustave Roussy
    Institut Gustave Roussy

    Villejuif, France

    Key Differentiators

    • Oncology
    • Melanoma

  • #4

    Moffitt Cancer Center
    Moffitt Cancer Center

    Tampa, Florida

    Key Differentiators

    • Oncology
    • Melanoma

  • #5

    The Wistar Institute
    The Wistar Institute

    Philadelphia, Pennsylvania

    Key Differentiators

    • Oncology
    • Melanoma

Original Source(s)

Intercellular mitochondrial transfer in melanoma progression and therapeutic resistance: mechanisms and targeting potential

  • by Qingqing Yan, Tao Sun, Kang Chen, Hao Hu

  • May 21, 2026

Related Content

From molecular networks to translational intervention: current progress in the mechanisms of gemcitabine resistance in bladder cancer

Outcomes of critically ill pediatric patients after haploidentical stem cell transplantation

Case Report: First description of an intracranial “NET” in ROHHAD syndrome; time to rename to the ROHHAD-NeCT syndrome?